Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Details

Title
Reply to Garnemark et al. The Swedish National Formulary for Children ePed. Comment on “Shaniv et al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on “Shaniv et al. Neonatal Drug Formularies—A Global Scope. Children 2023, 10, 848”. Children 2023, 10, 1803”
Author
Dotan Shaniv 1   VIAFID ORCID Logo  ; Smits, Anne 2   VIAFID ORCID Logo  ; Allegaert, Karel 3   VIAFID ORCID Logo  ; Carney, Paul R

 Pharmacy Services, Kaplan Medical Center (Clalit Health Services), Pasternak St., P.O. Box 1, Rehovot 76100, Israel; [email protected]; Neonatal Intensive Care Unit, Kaplan Medical Center (Clalit Health Services), Pasternak St., P.O. Box 1, Rehovot 76100, Israel 
 Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium; [email protected]; Neonatal Intensive Care Unit, University Hospitals Leuven, 3000 Leuven, Belgium 
 Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium; [email protected]; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium; Department of Hospital Pharmacy, Erasmus MC, 3015 GD Rotterdam, The Netherlands 
First page
1341
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
22279067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3132996877
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.